BPGM Antibody

2,3-Bisphosphoglycerate Mutase, Mouse Anti Human
Shipped with Ice Packs
In Stock

Product Specs

Introduction
Bisphosphoglycerate mutase (BPGM) is an enzyme that plays a crucial role in regulating oxygen delivery to tissues. It is highly concentrated in red blood cells, where it binds to hemoglobin and reduces its affinity for oxygen. This effect is vital for facilitating the release of oxygen from red blood cells to tissues. A deficiency in BPGM can lead to increased oxygen affinity of cells, impairing oxygen delivery. BPGM exhibits multifunctional enzymatic activity, catalyzing both the synthesis and degradation of 2,3-diphosphoglycerate (2,3-DPG). It accomplishes this through its synthetase activity, responsible for 2,3-DPG synthesis, and its phosphatase activity, which breaks down 2,3-DPG. Furthermore, BPGM possesses phosphoglycerate phosphomutase activity. Mutations in the BPGM gene can result in hemolytic anemia. While BPGM catalyzes the reactions of EC 5.4.2.1 (mutase) and EC 3.1.3.13 (phosphatase), it does so with reduced activity.
Physical Appearance
Sterile filtered colorless solution.
Formulation
The antibody is supplied as a 1 mg/ml solution in a buffer containing PBS at pH 7.4, 10% glycerol, and 0.02% sodium azide.
Storage Procedures
For short-term storage (up to 1 month), the antibody should be kept at 4°C. For extended storage, it is recommended to store at -20°C. Avoid repeated freeze-thaw cycles to maintain stability.
Stability / Shelf Life
The antibody remains stable for 12 months when stored at -20°C and for 1 month at 4°C.
Applications
This BPGM antibody has undergone rigorous testing in various applications, including ELISA, Western blot analysis, Flow cytometry, and ICC/IF, to ensure its specificity and reactivity. However, as with any antibody, it is essential to optimize the working concentration for each specific application to achieve optimal results.
Synonyms

Bisphosphoglycerate mutase, EC 5.4.2.4, BPGM, 2,3-bisphosphoglycerate mutase erythrocyte, 2,3-bisphosphoglycerate synthase, BPG-dependent PGAM.

Purification Method

BPGM antibody was purified from mouse ascitic fluids by protein-A affinity chromatography.

Type
Mouse Anti Human Monoclonal.
Clone

PA2E11AT.

Immunogen

Anti-human BPGM mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human BPGM amino acids 1-259 purified from E. coli.

Ig Subclass
Mouse IgG2a heavy chain and K light chain.

Q&A

What is BPGM and why is it significant in biological research?

BPGM (2,3-bisphosphoglycerate mutase) plays a crucial role in regulating hemoglobin oxygen affinity by controlling the levels of its allosteric effector 2,3-bisphosphoglycerate (2,3-BPG). This enzyme exhibits both synthase and mutase (EC 5.4.2.11) activities in erythrocytes, making it essential for oxygen transport regulation. Understanding BPGM function is critical for studies of erythrocyte metabolism, hemoglobin-oxygen binding dynamics, and related hematological disorders. The protein's molecular functions in controlling oxygen delivery to tissues make it a significant target for research into hypoxic conditions, altitude adaptation, and certain anemias .

What types of BPGM antibodies are available for research applications?

The majority of commercially available BPGM antibodies are rabbit polyclonal antibodies raised against various epitopes of human BPGM. These include antibodies targeting different regions of the protein, such as the N-terminal region, C-terminal region, or central domains. Full-length antibodies recognize amino acids 1-259, while others target specific segments (e.g., AA 85-216 or AA 230-259). Most are unconjugated and suitable for multiple applications including Western blotting, immunocytochemistry, and immunofluorescence. The polyclonal nature of these antibodies provides robust detection across multiple epitopes but may introduce variability between lots .

What species reactivity can researchers expect from BPGM antibodies?

While human reactivity is consistently reported across BPGM antibodies, cross-reactivity with other species varies by antibody. Some antibodies demonstrate reactivity only with human samples, while others show cross-reactivity with mouse samples. More broadly reactive antibodies may recognize BPGM in rat, cow, guinea pig, horse, rabbit, bat, and monkey samples, reflecting conservation of epitopes across species. When selecting an antibody for non-human research models, verifying the specific cross-reactivity profile is essential. Some antibodies, particularly those targeting highly conserved functional domains of BPGM, offer greater cross-species applicability .

What applications have been validated for BPGM antibodies?

BPGM antibodies have been validated for multiple experimental techniques, including:

  • Western Blotting (WB): Detecting BPGM at the expected 30 kDa molecular weight

  • Immunocytochemistry (ICC): Localizing BPGM within cellular compartments

  • Immunofluorescence (IF): Visualizing BPGM distribution patterns in fixed cells

  • Enzyme-Linked Immunosorbent Assay (ELISA): Quantifying BPGM protein content

  • Immunohistochemistry (IHC): Detecting BPGM in tissue sections

The most extensively validated applications are Western blotting and immunofluorescence, with established protocols for cell lines including 293T, A431, H1299, and HeLa .

How should researchers optimize Western blot protocols for BPGM detection?

For optimal Western blot detection of BPGM:

  • Sample preparation: Use whole cell lysates from relevant sources (293T, A431, H1299 cells have been validated)

  • Gel selection: 12% SDS-PAGE provides appropriate resolution for the 30 kDa BPGM protein

  • Antibody dilution: Begin with 1:1000 dilution for primary antibody incubation

  • Protein loading: 30 μg of whole cell lysate per lane has been demonstrated effective

  • Detection system: Both chemiluminescence and fluorescent secondary antibodies are suitable

  • Controls: Include positive control lysates with known BPGM expression

  • Blocking: Use 5% non-fat milk or BSA to minimize background

Researchers should anticipate a band at approximately 30 kDa, which is the predicted molecular weight for BPGM .

What protocol modifications are necessary for immunofluorescence detection of BPGM?

For immunofluorescence applications:

  • Fixation: Paraformaldehyde fixation has been validated for BPGM detection

  • Antibody dilution: Use a higher concentration (approximately 1:100) than for Western blotting

  • Permeabilization: Ensure appropriate membrane permeabilization for antibody access

  • Counterstaining: DAPI or other DNA probes help visualize cellular context

  • Controls: Include antibody omission controls to assess background

  • Mounting: Use anti-fade mounting medium to preserve signal

  • Imaging: Confocal microscopy may provide better resolution of subcellular localization

HeLa cells have been successfully used for immunofluorescence detection of BPGM as demonstrated in the literature .

How can researchers establish an ELISA system for BPGM quantification?

Based on published methodologies, an ELISA system for BPGM quantification can be established following these guidelines:

  • Antibody selection: Use a polyclonal anti-BPGM antibody with demonstrated specificity

  • Standard curve: Generate using recombinant human BPGM (rBPGM) protein

  • Assay range: The system can be reliable between 0.1 to 10 ng/mL of BPGM

  • Specificity validation: Confirm absence of cross-reactivity with homologous proteins like B-type phosphoglycerate mutase

  • Sample preparation: Standardize erythrocyte lysis procedures

  • Quality control: Aim for coefficient of variation under 1.5% for reproducibility

  • Reference range establishment: Normal values in human whole blood are approximately 56.3 ± 9.7 μg/mL

This approach enables quantitative assessment of BPGM protein levels for comparison across samples or experimental conditions .

How can BPGM antibodies be utilized to investigate erythrocyte function?

BPGM antibodies provide powerful tools for investigating erythrocyte metabolism and function:

  • Quantitative analysis: Measure BPGM protein levels in erythrocytes using ELISA or Western blotting

  • Comparative studies: Assess BPGM expression across different physiological states (exercise, altitude, disease)

  • Enzymopathy detection: Combine protein detection with activity assays to identify functional deficiencies

  • Correlation studies: Relate BPGM protein levels to 2,3-BPG concentrations and hemoglobin oxygen affinity

  • Genetic variation impact: Examine how BPGM polymorphisms affect protein expression and function

  • Developmental studies: Track BPGM expression changes during erythrocyte maturation

  • Pathophysiological investigation: Study BPGM alterations in hematological disorders

These approaches can help elucidate the role of BPGM in regulating oxygen transport under normal and pathological conditions .

What strategies can address cross-reactivity concerns with BPGM antibodies?

When addressing potential cross-reactivity issues:

  • Epitope selection: Choose antibodies targeting unique regions of BPGM with minimal homology to related proteins

  • Validation approaches: Perform peptide competition assays to confirm specificity

  • Control inclusion: Use recombinant human B-type phosphoglycerate mutase as a negative control

  • Purification methods: Consider antibody affinity purification against the specific target

  • Stringency optimization: Adjust washing conditions and blocking agents to reduce non-specific binding

  • Multiple antibody validation: Confirm findings using antibodies targeting different BPGM epitopes

  • Technical alternatives: Consider mass spectrometry-based approaches for absolute confirmation

The search results indicate that properly validated antibodies show no cross-reaction with the highly homologous B-type phosphoglycerate mutase, suggesting good specificity can be achieved .

How can researchers troubleshoot inconsistent results with BPGM antibodies?

When encountering inconsistent results:

  • Antibody validation: Verify antibody specificity using positive and negative controls

  • Sample preparation: Ensure consistent protein extraction and handling procedures

  • Protein degradation assessment: Check for proteolytic degradation with protease inhibitors

  • Lot-to-lot variation: Compare results across different antibody lots when possible

  • Protocol standardization: Maintain consistent incubation times, temperatures, and buffer compositions

  • Quantification methods: Use appropriate loading controls for Western blots

  • Expression level considerations: Be aware that BPGM expression varies between tissues and cell types

  • Technical replication: Perform multiple independent experiments to confirm findings

Implementing these approaches can help distinguish between technical artifacts and true biological variation .

What complementary techniques can enhance BPGM antibody-based research?

For comprehensive BPGM research, consider integrating these complementary approaches:

  • Enzyme activity assays: Correlate BPGM protein levels with functional activity

  • 2,3-BPG measurement: Quantify the product of BPGM activity to establish functional relationships

  • Oxygen-hemoglobin dissociation curves: Link BPGM expression to physiological oxygen binding

  • Genetic analysis: Sequence BPGM to identify polymorphisms or mutations affecting function

  • Metabolomic profiling: Examine broader impacts on erythrocyte metabolism

  • Protein-protein interaction studies: Identify BPGM binding partners

  • Transcriptional analysis: Investigate BPGM gene regulation under different conditions

  • Structural studies: Relate antibody binding epitopes to protein functional domains

This multi-technique approach provides a more comprehensive understanding of BPGM biology than antibody-based detection alone .

What controls are essential when using BPGM antibodies?

A robust experimental design should include these controls:

  • Positive controls: Cell lysates with confirmed BPGM expression (293T, A431, H1299 cells)

  • Negative controls: Samples with minimal BPGM expression

  • Antibody controls: Primary antibody omission to assess secondary antibody specificity

  • Isotype controls: Irrelevant antibodies of the same isotype to evaluate non-specific binding

  • Loading controls: Housekeeping proteins to normalize expression levels

  • Peptide competition: Pre-incubation with immunizing peptide to confirm specificity

  • Recombinant protein standards: Purified BPGM protein for quantification references

These controls help distinguish specific signals from technical artifacts and enable reliable data interpretation .

How should researchers interpret BPGM antibody results in relation to oxygen transport studies?

When interpreting BPGM antibody results in oxygen transport research:

  • Context consideration: Relate BPGM protein levels to physiological or pathological context

  • Functional correlation: Establish relationships between BPGM expression, 2,3-BPG levels, and oxygen affinity

  • Cell-specific expression: Account for erythrocyte-specific expression patterns

  • Environmental factors: Consider how hypoxia, pH, and other factors affect BPGM expression

  • Species differences: Recognize variations in BPGM structure and function across species

  • Developmental stage: Account for changes in BPGM expression during erythrocyte maturation

  • Pathological implications: Interpret results in context of disease mechanisms where oxygen transport is compromised

This multifaceted interpretation approach helps translate molecular findings to physiological significance .

What methodological considerations apply when studying BPGM in different species?

When extending BPGM research across species:

  • Antibody selection: Choose antibodies validated for cross-species reactivity or targeting highly conserved epitopes

  • Sequence alignment: Compare BPGM protein sequences across species to identify conserved regions

  • Epitope mapping: Determine if the antibody's target sequence is preserved in the species of interest

  • Validation requirements: Perform species-specific validation regardless of manufacturer claims

  • Control inclusion: Use tissue from the target species with known BPGM expression patterns

  • Dilution optimization: Adjust antibody concentrations for species-specific applications

  • Protocol adaptation: Modify fixation, extraction, or detection methods for species-specific tissues

These considerations ensure reliable detection of BPGM across experimental models from different species .

How might BPGM antibodies contribute to clinical research applications?

BPGM antibody applications in clinical research include:

  • Enzymopathy characterization: Detecting BPGM protein abnormalities in rare genetic disorders

  • Reference range establishment: Developing clinical reference ranges for BPGM protein content

  • Biomarker potential: Exploring BPGM as a biomarker for conditions affecting oxygen transport

  • Erythrocyte abnormality investigation: Studying BPGM in hematological disorders

  • High-altitude adaptation research: Examining BPGM expression changes in altitude-related studies

  • Exercise physiology: Investigating BPGM regulation during athletic training and performance

  • Anemia research: Characterizing BPGM alterations in different types of anemia

The established ELISA system with its reference range (56.3 ± 9.7 μg/mL in whole blood) provides a foundation for such clinical applications .

What methodological advances could improve BPGM antibody applications?

Future methodological improvements may include:

  • Development of monoclonal antibodies for greater consistency and specificity

  • Site-specific antibodies targeting functional domains of BPGM

  • Multiplexed detection systems for simultaneous analysis of BPGM and related proteins

  • Live-cell imaging techniques using non-interfering antibody fragments

  • Microfluidic platforms for high-throughput BPGM quantification

  • Automated image analysis algorithms for standardized immunofluorescence quantification

  • Single-cell analysis techniques to examine BPGM heterogeneity within erythrocyte populations

  • Nanobody development for improved penetration and reduced interference

These advances would expand the utility and reliability of BPGM antibodies in research applications .

How can researchers integrate BPGM antibody data with systems biology approaches?

Integration of BPGM antibody data with systems biology requires:

  • Multi-omics integration: Correlate BPGM protein levels with transcriptomic and metabolomic data

  • Network analysis: Position BPGM within erythrocyte metabolic networks

  • Mathematical modeling: Incorporate BPGM data into models of oxygen transport dynamics

  • Pathway analysis: Examine BPGM in context of glycolytic and related metabolic pathways

  • Computational prediction: Use structural data to predict BPGM interactions and regulation

  • Population-level analysis: Study BPGM variation across populations with different environmental adaptations

  • Time-course studies: Track BPGM dynamics during physiological responses

  • Data visualization: Develop integrated visualization tools for complex BPGM-related datasets

This integration enables a more comprehensive understanding of BPGM's role in cellular physiology and oxygen transport regulation .

Product Science Overview

Introduction

2,3-Bisphosphoglycerate Mutase (BPGM) is a multifunctional enzyme that plays a crucial role in the regulation of hemoglobin oxygen affinity by controlling the levels of its allosteric effector, 2,3-bisphosphoglycerate (2,3-BPG). This enzyme is encoded by the BPGM gene and is involved in both the synthesis and degradation of 2,3-BPG .

Structure and Function

BPGM is a member of the phosphoglycerate mutase family and exists as a homodimer. It catalyzes the conversion of 3-phospho-D-glyceroyl phosphate to 2,3-bisphospho-D-glycerate (2,3-BPG), a reaction essential for controlling the concentration of 2,3-BPG within the cell . The enzyme exhibits mutase activity (EC 5.4.2.11) and has phosphoglycerate phosphomutase activity .

Role in Hemoglobin Regulation

2,3-BPG is a small molecule found at high concentrations in red blood cells, where it binds to hemoglobin and decreases its oxygen affinity. This binding is crucial for the efficient release of oxygen to tissues. BPGM’s role in regulating 2,3-BPG levels is therefore vital for maintaining proper oxygen delivery throughout the body .

Genetic Aspects

The BPGM gene is located on chromosome 7 and has multiple alternatively spliced variants encoding the same protein . Mutations in this gene can lead to hemolytic anemia, a condition characterized by the destruction of red blood cells . Additionally, BPGM is associated with diseases such as Erythrocytosis, Familial, 8, and Autosomal Recessive Secondary Polycythemia .

Mouse Anti Human BPGM Antibody

Mouse anti-human BPGM antibodies are monoclonal antibodies used in various research applications, including Western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) . These antibodies are specific for an epitope within the internal region of the human BPGM protein and are used to detect BPGM expression in different tissues and cell types .

Research and Clinical Implications

Research on BPGM has significant implications for understanding and treating conditions related to oxygen delivery and red blood cell function. The enzyme’s role in hemoglobin regulation makes it a potential target for therapeutic interventions in diseases such as anemia and polycythemia .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.